116819
Adenosine 3′,5′-cyclic Monophosphorothioate, 8-Chloro-, Rp-Isomer, Sodium Salt
Rp-8-Cl-cAMPS, Na
Wenn Sie allgemeine Fragen haben, wenden Sie sich bitte an unseren Kundenservice:
Merck KGaA
Frankfurter Str. 250
64293 Darmstadt
Germany
Telefon: +49 6151 72-0
Fax: +49 6151 72 2000
15 Februar 2012
wird geladen
A cell-permeable, metabolically-stable analog of cAMP that acts as a competitive inhibitor of protein kinase A. Lipophilic analog of the cAMP antagonist Rp-cAMPS (Cat. No. 116814). Preferentially inhibits type I PKA (IC50 = ~50 µM).
Note: 5 µmol = 2 mg.
| Produktinformationen | |||
|---|---|---|---|
| Form | Lyophilized | ||
| Primary Target | PKA 1 | ||
| Primary Target IC50 | 50 µM | ||
| Secondary target | Cholera toxin (IC50=300 µM) | ||
| Hygrocopic | Ja | ||
| Cell permeable | Ja | ||
| ATP Competitive | Ja | ||
| Purity | ≥98% by HPLC | ||
| Chemische Formel | C10H10ClN5O5PS · Na | ||
| CAS-Nummer | 142754-27-6 | ||
| Declaration | Sold under license of Patent DE 3,802,865.4 issued to BIOLOG LSI. | ||
| Lager- und Versandinformationen | |||
|---|---|---|---|
| Lagerkategorie | -20°C | ||
| Ship |
Ambient Temperature Only
Standard Handling |
||
